Dr. Stuart Hetrick, D.O

NPI: 1932101730
Total Payments
$73,003
2024 Payments
$89.00
Companies
79
Transactions
845
Medicare Patients
23,829
Medicare Billing
$6.9M

Payment Breakdown by Category

Other$43,900 (60.1%)
Food & Beverage$17,292 (23.7%)
Consulting$5,500 (7.5%)
Travel$4,205 (5.8%)
Research$1,472 (2.0%)
Gifts$491.58 (0.7%)
Education$142.17 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $43,900 31 60.1%
Food and Beverage $17,292 785 23.7%
Consulting Fee $5,500 2 7.5%
Travel and Lodging $4,205 22 5.8%
Unspecified $1,472 2 2.0%
Gift $491.58 1 0.7%
Education $142.17 2 0.2%

Payments by Type

General
$71,530
843 transactions
Research
$1,472
2 transactions

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $51,781 139 $0 (2022)
ABBVIE INC. $5,266 64 $0 (2023)
Novartis Pharmaceuticals Corporation $2,324 76 $0 (2023)
Eli Lilly and Company $1,472 2 $0 (2022)
Biogen, Inc. $941.42 38 $0 (2023)
Amgen Inc. $898.76 36 $0 (2022)
Sunovion Pharmaceuticals Inc. $683.02 68 $0 (2022)
Teva Pharmaceuticals USA, Inc. $649.44 22 $0 (2023)
Mallinckrodt Enterprises LLC $648.16 28 $0 (2019)
GENZYME CORPORATION $552.21 23 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $89.00 5 Celgene Corporation ($34.53)
2023 $1,285 40 Novartis Pharmaceuticals Corporation ($343.46)
2022 $8,185 94 ABBVIE INC. ($4,672)
2021 $13,744 124 Allergan, Inc. ($11,492)
2020 $7,752 129 Allergan, Inc. ($5,999)
2019 $19,100 152 Allergan Inc. ($16,090)
2018 $10,673 139 Allergan Inc. ($7,992)
2017 $12,174 162 Allergan Inc. ($9,571)

All Payment Transactions

845 individual payment records from CMS Open Payments — Page 1 of 34

Date Company Product Nature Form Amount Type
07/19/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $20.80 General
Category: Neuroscience
04/22/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $13.73 General
Category: Neuroscience
03/27/2024 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $14.09 General
Category: Neuromodulation
02/16/2024 Abbott Laboratories INFINITY (Device) Food and Beverage In-kind items and services $13.67 General
Category: Neuromodulation
01/19/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $26.71 General
11/14/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $11.53 General
Category: Neurology
08/12/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $27.06 General
Category: NEUROSCIENCE
07/10/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $20.27 General
Category: NEUROSCIENCE
06/30/2023 ABBVIE INC. DUOPA (Drug) Food and Beverage In-kind items and services $22.97 General
Category: NEUROSCIENCE
06/14/2023 Lilly USA, LLC EMGALITY (Drug), REYVOW Food and Beverage In-kind items and services $13.53 General
Category: Neuroscience
06/13/2023 Horizon Therapeutics plc UPLIZNA (Drug) Food and Beverage In-kind items and services $77.10 General
Category: UPLIZNA
06/09/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $22.82 General
Category: NEUROSCIENCE
05/30/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $11.10 General
Category: NEUROSCIENCE
05/24/2023 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $117.20 General
Category: NEUROSCIENCE
05/24/2023 Horizon Therapeutics plc UPLIZNA (Drug) Food and Beverage In-kind items and services $14.50 General
Category: UPLIZNA
05/23/2023 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $6.50 General
Category: BOTOX THERAPEUTIC
05/20/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $20.21 General
Category: NEUROSCIENCE
05/10/2023 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $10.27 General
Category: BOTOX THERAPEUTIC
05/01/2023 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Immunology
04/27/2023 Nevro Corp. Senza (Device) Food and Beverage In-kind items and services $17.85 General
Category: Spinal Cord Stimulator
04/20/2023 GENZYME CORPORATION Food and Beverage In-kind items and services $12.99 General
04/19/2023 Biogen, Inc. VUMERITY (Drug) Food and Beverage In-kind items and services $19.43 General
Category: Neurology
04/06/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $18.23 General
Category: Neurology
04/05/2023 BANNER LIFE SCIENCES, LLC BAFIERTAM (Drug) Food and Beverage In-kind items and services $16.89 General
Category: Immune
03/25/2023 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $25.07 General
Category: BOTOX THERAPEUTIC

Research Studies & Clinical Trials

Study Name Company Amount Records
A PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GALCANEZUMAB VERSUS RIMEGEPANT IN ADULT PARTICIPANTS WITH EPISODIC MIGRAINE Eli Lilly and Company $1,472 2

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 61 6,738 172,027 $3.5M $2.0M
2022 61 7,733 145,787 $4.2M $2.4M
2021 52 5,000 107,159 $2.3M $1.4M
2020 53 4,358 84,940 $1.9M $1.0M
Total Patients
23,829
Total Services
509,913
Medicare Billing
$6.9M
Procedure Codes
227

All Medicare Procedures & Services

227 procedure records from CMS Medicare Utilization — Page 1 of 10

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 245 147,947 $1.2M $717,300 60.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 1,204 4,539 $862,410 $569,353 66.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 838 1,779 $249,060 $159,594 64.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 578 578 $156,060 $85,275 54.6%
64646 Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles Office 2023 208 643 $125,385 $72,288 57.7%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2023 222 683 $129,770 $43,011 33.1%
90837 Psychotherapy, 1 hour Office 2023 62 322 $56,350 $33,116 58.8%
64450 Injection of anesthetic agent and/or steroid into other nerve or branch Office 2023 80 370 $58,800 $25,268 43.0%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 92 520 $49,400 $23,346 47.3%
98929 Osteopathic manipulative treatment, 9-10 body regions Office 2023 29 391 $44,965 $22,965 51.1%
97112 Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes Office 2023 29 925 $41,625 $18,209 43.7%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 178 223 $26,880 $16,632 61.9%
96116 Exam of neurobehavioral status, first hour Office 2023 176 223 $27,875 $15,836 56.8%
95913 Nerve conduction, 13 or more studies Office 2023 71 75 $29,250 $14,936 51.1%
95911 Nerve conduction, 9-10 studies Office 2023 78 85 $26,350 $14,000 53.1%
96132 Evaluation of neuropsychological test, first hour Office 2023 135 138 $24,150 $13,556 56.1%
96374 Injection of drug or substance into vein Office 2023 89 475 $35,625 $13,403 37.6%
96125 Test to assess the ability to complete specific functional tasks applicable to environment Office 2023 83 165 $23,100 $13,139 56.9%
64400 Injection of anesthetic agent and/or steroid into face nerve Office 2023 28 118 $25,170 $11,126 44.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 124 160 $15,200 $9,357 61.6%
20553 Injection of trigger points, 3 or more muscles Office 2023 77 330 $28,050 $8,769 31.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 167 189 $11,340 $8,027 70.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 62 62 $13,330 $7,147 53.6%
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour Office 2023 56 463 $13,890 $7,125 51.3%
96375 Injection of additional new drug or substance into vein Office 2023 66 660 $19,800 $6,813 34.4%

About Dr. Stuart Hetrick, D.O

Dr. Stuart Hetrick, D.O is a Neurology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932101730.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Hetrick, D.O has received a total of $73,003 in payments from pharmaceutical and medical device companies, with $89.00 received in 2024. These payments were reported across 845 transactions from 79 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,900).

As a Medicare-enrolled provider, Hetrick has provided services to 23,829 Medicare beneficiaries, totaling 509,913 services with total Medicare billing of $6.9M. Data is available for 4 years (2020–2023), covering 227 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Phoenix, AZ
  • Active Since 08/11/2005
  • Last Updated 03/31/2021
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1932101730

Products in Payments

  • BOTOX (Biological) $28,988
  • BOTOX (Drug) $15,990
  • BOTOX CHRONIC MIGRAINE (Drug) $6,267
  • UBRELVY (Drug) $5,414
  • Aimovig (Biological) $885.79
  • KESIMPTA (Drug) $814.84
  • AIMOVIG (Biological) $794.23
  • ACTHAR (Biological) $714.90
  • APTIOM (Drug) $662.17
  • OCREVUS (Biological) $515.03
  • GILENYA (Drug) $511.73
  • Humphrey HFA (Device) $491.58
  • TYSABRI (Biological) $329.52
  • SOLIRIS (Drug) $317.81
  • AUBAGIO (Drug) $294.76
  • Briviact (Drug) $284.12
  • VYEPTI (Biological) $259.60
  • Nalocet (Drug) $246.48
  • ZEPOSIA (Drug) $232.66
  • LEMTRADA (Drug) $228.02

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Phoenix